Number of the records: 1  

12-O-Tetradecanoylphor bol-13-acetate increases cardiomyogenesis through PKC/ERK signaling

  1. 1.
    0537569 - BFÚ 2021 RIV GB eng J - Journal Article
    Radaszkiewicz, K. A. - Beckerov, D. - Woloszczukov, L. - Radaszkiewicz, T.W. - Lesakov, P. - Blanářová, O. - Kubala, Lukáš - Humpolíček, P. - Pacherník, J.
    12-O-Tetradecanoylphor bol-13-acetate increases cardiomyogenesis through PKC/ERK signaling.
    Scientific Reports. Roč. 10, č. 1 (2020), č. článku 15922. ISSN 2045-2322. E-ISSN 2045-2322
    Institutional support: RVO:68081707
    Keywords : protein-kinase-c * embryonic stem-cells * transcription factor gata4 * hl-60 cells * differentiation * cardiomyocytes
    OECD category: Biophysics
    Impact factor: 4.380, year: 2020
    Method of publishing: Open access
    http://apps.webofknowledge.com/InboundService.do?customersID=Alerting&mode=FullRecord&IsProductCode=Yes&product=WOS&Init=Yes&Func=Frame&DestFail=http%3A%2F%2Fwww.webofknowledge.com&action=retrieve&SrcApp=Alerting&SrcAuth=Alerting&SID=E67B63irIgusvnWIdyQ&UT=WOS%3A000577348000016

    12-O-Tetradecanoylphorbol-13-acetate (TPA) is the most widely used diacylglycerol (DAG) mimetic agent and inducer of protein kinase C (PKC)-mediated cellular response in biomedical studies. TPA has been proposed as a pluripotent cell differentiation factor, but results obtained have been inconsistent. In the present study we show that TPA can be applied as a cardiomyogenesis-promoting factor for the differentiation of mouse embryonic stem (mES) cells in vitro. The mechanism of TPA action is mediated by the induction of extracellular signal-regulated kinase (ERK) activity and the subsequent phosphorylation of GATA4 transcription factor. Interestingly, general mitogens (FGF, EGF, VEGF and serum) or canonical WNT signalling did not mimic the effect of TPA. Moreover, on the basis of our results, we postulate that a TPA-sensitive population of cardiac progenitor cells exists at a certain time point (after days 6-8 of the differentiation protocol) and that the proposed treatment can be used to increase the multiplication of ES cell-derived cardiomyocytes.
    Permanent Link: http://hdl.handle.net/11104/0315400

     
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.